RNU6-795P

Across TCGA pan-cancer cohorts, RNU6-795P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-795P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-795P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-795P expression acts as an unfavorable survival marker, although some lineages such as LUAD and BLCA show a favorable association.

ACC, TGCT, and KIRP are the cancer types where RNU6-795P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	III,IV	0.245	0.656	<.001	54	view →
TGCT	DFS	Tertile	III,IV	0.340	1.000	.002	54	view →
KIRP	DFS	Tertile	III,IV	0.253	0.679	.001	42	view →
KICH	DFS	Quartile	All	0.487	1.000	.001	38	view →
GBM	DFS	Tertile	All	0.097	0.267	<.001	18	view →
READ	DFS	Tertile	IV	0.268	0.709	.002	18	view →
LUAD	OS	Tertile	All	0.630	0.259	.013	18	view →
THCA	DFS	Quartile	All	0.730	0.878	.010	16	view →
BRCA	OS	Tertile	III,IV	0.438	0.615	.017	13	view →
BLCA	OS	Tertile	IV	0.771	0.281	.009	12	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	9	view →
LIHC	DFS	Tertile	All	0.393	0.570	.029	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-795P–ACC (OS)

Open the ACC breakdown →